Thomas Martens, MD
Medical Director,
International Diabetes Center- HealthPartners Institute
2026 Presenter Profile
When
Saturday, June 6
at 3:15 p.m. CT
Where
R05 (Level 2)
Ernest N. Morial Convention Center
ADA Statement on Diabetes Technology in Primary Care

What is your presentation about?
This presentation will review the current status of use of continuous glucose monitoring (CGM) in primary care settings. We will discuss current use, current barriers, and opportunities for future optimization.
How do you hope your presentation will impact diabetes research or care?
While there has been significant uptake in the use of continuous glucose monitoring in primary care settings, opportunities remain in improving access to all populations that may benefit from this technology, including populations with great need but significant barriers to access to both newer therapeutics and technologies in managing diabetes. Additionally, opportunities remain in improving access to the data generated by CGM when working with people with diabetes in primary care settings, and in improving the knowledgebase of primary care clinicians in discussing therapeutic options through shared decision-making. My hope is that by making these opportunities more visible, we will continue to make progress in optimally using this innovative technology for all people who may benefit.
How did you become involved with this area of diabetes research or care?
I have worked as a frontline primary care clinician for my whole career, and continue to split my time between primary care medical practice and research at the International Diabetes Center. Primary care is the “front door” of the American medical system; up to 90% of people with diabetes receive their care through primary care settings. My medical practice has shown me both the challenges and barriers people face in managing their diabetes, and also the tremendous opportunity for improving heath through improving diabetes care delivery. My hope is that by improving the way we use technology and therapeutics in primary care, we can make excellent health across the lifespan both easier to achieve and more achievable.

